These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 34878305)

  • 1. Delineation of the Direct Contribution of Candida auris
    Rybak JM; Sharma C; Doorley LA; Barker KS; Palmer GE; Rogers PD
    Microbiol Spectr; 2021 Dec; 9(3):e0158521. PubMed ID: 34878305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Erg11 Amino Acid Substitutions Identified in Candida auris Clade III Isolates on Triazole Drug Susceptibility.
    Williamson B; Wilk A; Guerrero KD; Mikulski TD; Elias TN; Sawh I; Cancino-Prado G; Gardam D; Heath CH; Govender NP; Perlin DS; Kordalewska M; Healey KR
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0162421. PubMed ID: 34633842
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutations in
    Rybak JM; Muñoz JF; Barker KS; Parker JE; Esquivel BD; Berkow EL; Lockhart SR; Gade L; Palmer GE; White TC; Kelly SL; Cuomo CA; Rogers PD
    mBio; 2020 May; 11(3):. PubMed ID: 32398311
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid Detection of
    Hou X; Lee A; Jiménez-Ortigosa C; Kordalewska M; Perlin DS; Zhao Y
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397051
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutations in TAC1 and ERG11 are major drivers of triazole antifungal resistance in clinical isolates of Candida parapsilosis.
    Doorley LA; Barker KS; Zhang Q; Rybak JM; Rogers PD
    Clin Microbiol Infect; 2023 Dec; 29(12):1602.e1-1602.e7. PubMed ID: 37666448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs.
    Ahmad S; Khan Z; Al-Sweih N; Alfouzan W; Joseph L
    Mycoses; 2020 Jan; 63(1):104-112. PubMed ID: 31618799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India.
    Singh A; Singh PK; de Groot T; Kumar A; Mathur P; Tarai B; Sachdeva N; Upadhyaya G; Sarma S; Meis JF; Chowdhary A
    J Antimicrob Chemother; 2019 May; 74(5):1260-1268. PubMed ID: 30753525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of Triazole Resistance upon Deletion of
    Rybak JM; Doorley LA; Nishimoto AT; Barker KS; Palmer GE; Rogers PD
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718246
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
    Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent increase in
    Castanheira M; Deshpande LM; Rhomberg PR; Carvalhaes CG
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0057024. PubMed ID: 39264189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance
    Burrack LS; Todd RT; Soisangwan N; Wiederhold NP; Selmecki A
    mBio; 2022 Aug; 13(4):e0084222. PubMed ID: 35862787
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Nishimoto AT; Wiederhold NP; Flowers SA; Zhang Q; Kelly SL; Morschhäuser J; Yates CM; Hoekstra WJ; Schotzinger RJ; Garvey EP; Rogers PD
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates.
    Jin L; Cao Z; Wang Q; Wang Y; Wang X; Chen H; Wang H
    BMC Infect Dis; 2018 Apr; 18(1):162. PubMed ID: 29631565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing.
    Wang H; Kong F; Sorrell TC; Wang B; McNicholas P; Pantarat N; Ellis D; Xiao M; Widmer F; Chen SC
    BMC Microbiol; 2009 Aug; 9():167. PubMed ID: 19682357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of the novel sixth
    Khan T; Faysal NI; Hossain MM; Mah-E-Muneer S; Haider A; Moon SB; Sen D; Ahmed D; Parnell LA; Jubair M; Chow NA; Chowdhury F; Rahman M
    Microbiol Spectr; 2024 Jul; 12(7):e0354023. PubMed ID: 38842332
    [No Abstract]   [Full Text] [Related]  

  • 16. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans.
    Heilmann CJ; Schneider S; Barker KS; Rogers PD; Morschhäuser J
    Antimicrob Agents Chemother; 2010 Jan; 54(1):353-9. PubMed ID: 19884367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering the Mrr1/Mdr1 Pathway in Azole Resistance of Candida auris.
    Li J; Coste AT; Bachmann D; Sanglard D; Lamoth F
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0006722. PubMed ID: 35343781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
    J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans.
    Flowers SA; Colón B; Whaley SG; Schuler MA; Rogers PD
    Antimicrob Agents Chemother; 2015 Jan; 59(1):450-60. PubMed ID: 25385095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.